Jang Dae Sik, Lee Ga Young, Kim Young Sook, Lee Yun Mi, Kim Chan-Sik, Yoo Jeong Lim, Kim Jin Sook
Department of Herbal Pharmaceutical Development, Korea Institute of Oriental Medicine, 461-24 Jeonmin-dong, Yuseong-gu, Daejeon, Korea.
Biol Pharm Bull. 2007 Nov;30(11):2207-10. doi: 10.1248/bpb.30.2207.
Nine anthraquinones, aurantio-obtusin (1), chryso-obtusin (2), obtusin (3), chryso-obtusin-2-O-beta-D-glucoside (4), physcion (5), emodin (6), chrysophanol (7), obtusifolin (8), and obtusifolin-2-O-beta-D-glucoside (9), isolated from an EtOAc-soluble extract of the seeds of Cassia tora, were subjected to in vitro bioassays to evaluate their inhibitory activity against advanced glycation end products (AGEs) formation and rat lens aldose reductase (RLAR). Among the isolates, compounds 6 and 8 exhibited a significant inhibitory activity on AGEs formation with observed IC(50) values of 118 and 28.9 microM, respectively, in an AGEs-bovine serum albumin (BSA) assay by specific fluorescence. Furthermore, compounds 6 and 8 inhibited AGEs-BSA formation more effectively than aminoguanidine, an AGEs inhibitor, by indirect AGEs-ELISA. N(epsilon)-Carboxymethyllysine (CML)-BSA formation was also inhibited by compounds 6 and 8. Whereas compounds 1, 4, and 6 showed a significant inhibitory activity on RLAR with IC(50) values of 13.6, 8.8, and 15.9 microM, respectively.
从决明子种子的乙酸乙酯可溶提取物中分离得到9种蒽醌类化合物,即橙钝叶决明素(1)、黄钝叶决明素(2)、钝叶决明素(3)、黄钝叶决明素-2-O-β-D-葡萄糖苷(4)、大黄素甲醚(5)、大黄素(6)、大黄酚(7)、钝叶决明苷(8)和钝叶决明苷-2-O-β-D-葡萄糖苷(9),对其进行体外生物测定,以评估它们对晚期糖基化终产物(AGEs)形成和大鼠晶状体醛糖还原酶(RLAR)的抑制活性。在这些分离物中,化合物6和8在AGEs-牛血清白蛋白(BSA)特异性荧光测定中对AGEs形成表现出显著的抑制活性,观察到的IC50值分别为118和28.9 microM。此外,通过间接AGEs-ELISA,化合物6和8比AGEs抑制剂氨基胍更有效地抑制AGEs-BSA的形成。化合物6和8也抑制了N-ε-羧甲基赖氨酸(CML)-BSA的形成。而化合物1、4和6对RLAR表现出显著的抑制活性,IC50值分别为13.6、8.8和15.9 microM。